Literature DB >> 19421168

Chronic GVHD manifesting as parotitis after allogeneic hematopoietic SCT.

D Z Drew, T Donohue, C Ramos, L Cook, R Goodwin, N Patronas, D Arrington, M Ramanathan, R Childs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19421168      PMCID： PMC4214382          DOI： 10.1038/bmt.2009.79

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.

Authors:  Ramaprasad Srinivasan; Yoshiyuki Takahashi; J Philip McCoy; Igor Espinoza-Delgado; Colleen Dorrance; Takehito Igarashi; Andreas Lundqvist; A John Barrett; Neal S Young; Nancy Geller; Richard W Childs
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

2.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742
  2 in total
  1 in total

Review 1.  Eosinophilic sialodochitis: redefinition of 'allergic parotitis' and 'sialodochitis fibrinosa'.

Authors:  A N Baer; A Okuhama; D W Eisele; J R Tversky; T J Gniadek
Journal:  Oral Dis       Date:  2016-12-06       Impact factor: 3.511
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.